Facts 2014-2015
Total Page:16
File Type:pdf, Size:1020Kb
facts 2014-2015 Caesar, leukemia survivor Gloria, myeloma survivor Jude, lymphoma survivor Virginia, leukemia survivor LLS exists to find cures and ensure access to the most appropriate treatments for all blood cancer patients. www.lls.org Table of Contents Executive Summary 1 Figures About Blood Cancer Therapy 2 1 Figure 1. Five-Year Relative Survival Rates by Year of Drug and Radiation Therapy Diagnosis 1960-1963 vs 1975-1977 vs 2004-2010 Stem Cell Transplantation 3 Figure 2. Estimated New Cases (%) of Leukemia, Lymphoma and Myeloma, 2014 Quality of Life, Palliative Care and Psychosocial Distress Screening 9 Figure 3. Estimated Proportion of New Cases (%) in 2014 for Survivorship Types of Leukemia, Adults and Children Leukemia 8 10 Figure 4. Age-Specific Incidence Rates for Acute Myeloid Living With Leukemia Leukemia (All Races), 2007-2011 New Cases 11 Figure 5. Five-Year Relative Survival Rates for All Ages, Incidence All Types of Leukemia, 1975-2010 Signs and Symptoms 11 Figure 6. Five-Year Relative Survival Rates for Acute Lymphoblastic Leukemia in Children under 15, Diagnosed Possible Causes 1964-2010 Treatment 14 Figure 7. Age-Specific Incidence Rates for Hodgkin Survival Lymphoma, 2007-2011 Deaths 14 Figure 8. Age-Specific Incidence Rates for Non-Hodgkin Hodgkin and Non-Hodgkin Lymphoma 12 Lymphoma, 2007-2011 Living With Lymphoma 17 Figure 9. Age-Specific Incidence Rates for Myeloma, 2007-2011 New Cases Incidence Signs and Symptoms Tables The Four Major Types of Leukemia Possible Causes 8 Table 1. 8 Table 2. Approximate US Prevalence of the Four Major Treatment Types of Leukemia as of January 1, 2011 Survival 9 Table 3. Total Estimated Number of New Leukemia Cases in Deaths the United States for 2014 Myeloma 17 11 Table 4. Estimated Deaths (All Age-groups) from All Types of Living With Myeloma Leukemia, 2014 New Cases 12 Table 5. New Cases of Lymphoma by Gender, 2014 Incidence 15 Table 6. Trends in Five-Year Relative Survival Rates by Race Signs and Symptoms for Hodgkin Lymphoma and Non-Hodgkin Lymphoma Possible Causes 16 Table 7. Observed-to-Expected Ratio for Developing Subsequent Primary Cancer after Hodgkin Lymphoma (HL) Treatment by Age at Diagnosis of HL, SEER 1973-2011 Survival 16 Table 8. Observed-to-Expected Ratio for Developing Deaths Subsequent Primary Cancer after Non-Hodgkin Lymphoma (NHL) by Age at Diagnosis of NHL, SEER 1973-2011 Myelodysplastic Syndromes 19 Living With Myelodysplastic Syndromes 16 Table 9. Estimated Deaths from Hodgkin Lymphoma and Non-Hodgkin Lymphoma, by Gender, 2014 New Cases 19 Table 10. Myelodysplastic Syndromes Incidence Rates, Incidence 2007-2011 Signs and Symptoms 20 Table 11. Incidence Rates by Gender, All Races, per Possible Causes 100,000 Population, 2007-2011 Treatment 20 Table 12. Incidence Rates by Gender, for Blacks, per Survival 100,000 Population, 2007-2011 Deaths 20 Table 13. Incidence Rates by Gender, for Whites, per 100,000 Population, 2007-2011 Incidence Rates: Leukemia, Lymphoma, Myeloma and 21 Table 14. Estimated New Cases of Blood Cancers by Site, Myelodysplastic Syndromes 20 by State, 2014 Estimated New Cases and Estimated Deaths by State 21 21 Table 15. Estimated Deaths from Blood Cancers by Site, Five-Year Incidence and Mortality Cases by State, 2007-2011 22 by State, 2014 Five-Year Leukemia Incidence and Mortality Cases by State, 2007-2011 23 22 Table 16. Five-Year Blood Cancer Incidence Cases by State, Notes and Definitions 24 2007-2011 About The Leukemia & Lymphoma Society 26 22 Table 17. Five-Year Blood Cancer Mortality Cases by State, 2007-2011 Citations and Acknowledgements 29 23 Table 18. Five-Year Leukemia Incidence Cases by State, 2007-2011 23 Table 19. Five-Year Leukemia Mortality Cases by State, 2007-2011 Executive Summary Facts 2014-2015 is an update of current data available to or the same as data reported in 2013: leukemia 13.0, for leukemia, lymphoma, myeloma and myelodysplastic 2014 vs 12.8, 2013; non-Hodgkin lymphoma (NHL) 19.7, syndromes* (blood cancers). Blood cancers are diseases 2014, same as 2013; Hodgkin lymphoma (HL) 2.7, 2014 that can affect the bone marrow, the blood cells, the vs 2.8, 2013; myeloma 6.1, 2014 vs 5.9, 2013. lymph nodes and other parts of the lymphatic system. Leukemia (26.9 percent), neoplasms of the brain and Facts 2014-2015 provides updates from The American other nervous tissue (17.7 percent), HL (6.9 percent), Cancer Society’s Cancer Facts and Figures 2014 for NHL (6.3 percent) and soft tissue (6.3 percent) are the estimated new blood cancer cases and estimated deaths most common types of cancer in children, adolescents due to blood cancers. The incidence, prevalence and and young adults younger than 20 years. mortality data in Facts 2014-2015 reflect the statistics from the National Cancer Institute’s Surveillance, Survival Epidemiology and End Results (SEER) Program, Cancer Relative survival compares the survival rate of a person Statistics Review (CSR) 1975-2011. The SEER Cancer diagnosed with a disease to that of a person without the Statistics Review was published online in April 2014 disease. The most recent survival data available may and updated in September 2014 (www.seer.cancer. not fully represent the outcomes of all current therapies gov). Incidence rates by state are provided by the North and, as a result, may underestimate survival to a small American Association of Central Cancer Registries degree. Figure 1 shows the five-year relative survival Cancer in North America, 2007-2011 (www.naaccr.org). rates for leukemia, lymphoma and myeloma during 1960-1963, 1975-1977 and 2004-2010. Facts 2014-2015 also provides current and accurate information about symptoms, risk factors and treatment. Five-Year Relative Survival Rates by Year of Diagnosis About Blood Cancer Therapy on page 2 provides an 1960-1963 vs 1975-1977 vs 2004-2010 overview of the therapies used to treat individuals with 90% 88* 81% these diseases. 72 71* 72% *Data specified for “leukemia, lymphoma and myeloma” do not include 63% 60* data for myelodysplastic syndromes. 54% 47* 47 45% 40 36% 31 34 27% 25 Survival Rates, % 18% 12 14 Highlights From Facts 2014-2015 9% 0% New Cases Myeloma Hodgkin Non-Hodgkin Leukemia Lymphoma Lymphoma Approximately every 3 minutes one person in the United 1960-19631 1975-1977 2004-2010 States is diagnosed with a blood cancer. Figure 1. Source: SEER (Surveillance, Epidemiology and End Results) Cancer l An estimated combined total of 156,420 people in Statistics Review, 1975-2011. National Cancer Institute; 2014. * The difference in rates between 1975-1977 and 2004-2010 is statistically the US are expected to be diagnosed with leukemia, significant (P< .05). lymphoma or myeloma in 2014. 1Survival rate among whites (only data available). l New cases of leukemia, lymphoma and myeloma are expected to account for 9.4 percent of the An estimated 1,185,053 people in the US are either estimated 1,665,540 new cancer cases diagnosed living with, or are in remission from, leukemia, lymphoma in the US in 2014. or myeloma. Incidence Deaths Incidence rates are the number of new cases in a given Approximately every 10 minutes, someone in the US dies year, not counting the pre-existing cases. The incidence from a blood cancer. This statistic represents nearly 152 rates are usually presented as a specific number per people each day or more than six people every hour. 100,000 population. l Leukemia, lymphoma and myeloma are expected to Overall incidence rates per 100,000 population reported cause the deaths of an estimated 55,350 people in the in 2014 for leukemia, lymphoma and myeloma are close US in 2014. Facts 2014-2015 I page 1 l These diseases are expected to account for 9.4 Myeloma percent of the deaths from cancer in 2014, based on l the estimated total of 585,720 cancer deaths. There are an estimated 95,874 people either living l with, or in remission from, myeloma in the US. In general, the likelihood of dying from most types l of leukemia, lymphoma or myeloma decreased from In 2014, 24,050 people are expected to be diagnosed 2000 to 2011 (the most recent data available). with myeloma. l The median age at diagnosis is 69 years; myeloma is Leukemia seldom diagnosed in people under age 45. l There are an estimated 327,520 people living with, or l In 2014, approximately 11,090 people are expected to in remission from, leukemia in the US. die from myeloma. l In 2014, 52,380 people are expected to be diagnosed l From 1975 to 2011, the incidence of myeloma with leukemia. increased by 36.1 percent. l In 2014, 24,090 people are expected to die from l The incidence of myeloma in black males and females leukemia. was 120 percent greater than myeloma incidence in l Approximately 33 percent more males are living with white males and females in 2011. leukemia than females. More males than females are l Overall, mortality from myeloma has been decreasing diagnosed with leukemia and die of leukemia. slightly from 1995 to 2011 (the most recent data available). Hodgkin and Non-Hodgkin Myelodysplastic Syndromes Lymphoma l There were an estimated 14,778 new cases of l There are an estimated 761,659 people living with, or myelodysplastic syndromes (MDS) diagnosed each in remission from, lymphoma in the US. year from 2007 to 2011. l For HL, an estimated 177,526 people are living with the l The estimated overall incidence rate of MDS is 4.9 disease or are in remission. cases per 100,000 population. White males have l For NHL, an estimated 584,133 people are living with the highest MDS incidence rates (6.9 per 100,000 the disease or are in remission.